Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220030/S009

UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE C3F8 Ophthalmic Gas in the UNIPEXY Gas Delivery

Alcon Research, LLC · Decision date Jan 8, 2026

FDA DECISIONP220030/S009

What did the FDA decide?

FDA records P220030/S009 as a supplement to PMA P220030, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 8, 2026.

FDA approval order statement

Approval to implement the following manufacturing changes to UNIFEYE and UNIPEXY Gas Delivery Systems: 1) replacement of the existing welding system at Picocyl, the supplier responsible for producing the pico-cylinder component, and 2) design update to the fill head component of the ALL02 Gas Filling System.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Jan 8, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P220030/S009
Regulatory pathway
PMA supplement
Product code
LPO
Decision code
OK30
Decision date
Jan 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Gases used within eye to place pressure on detached retina.

Product code
LPO
FDA device class
3

For the original device and its historical approval scope, see PMA P220030. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220030 · Original PMA

    UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE C3F8 Ophthalmic Gas in the UNIPEXY Gas Delivery

  2. P220030/S009 received

    Application receipt date recorded by FDA.

  3. P220030/S009 · FDA decision

    30-Day Notice

  4. P220030/S008 · Related supplement

    UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System

  5. P220030/S010 · Related supplement

    UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE C3F8 Ophthalmic Gas in the UNIPEXY Gas Delivery

  6. P220030/S011 · Related supplement

    UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System

  7. P220030/S012 · Related supplement

    UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System

Timeline entries are records held by MedtechLedger for P220030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220030

Explore the linked device profile

Other records with product code LPO

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Alcon Research, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
20511 Lake Forest Dr., Lake Forest, CA, 92630

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records